Philadelphia Union’s Post

leadership starts with the best

Getting closer

How much do I love working with our team. We are friends, colleagues, mentors to each other. And we dance together from all corners of the country because connection before content is key! pLink Leadership Also I can't be sure but it looks like Cindy Jackson PCC (she/her) is about to booty bump me! #getonthedancefloor #positiveleadership #plinkleadership #loveyourteam #leadershipdevelopment

Batman & Robin. Tom & Jerry. Han Solo & Chewbacca. When you think of iconic duos, you can add Pavilion and Carabiner Group to the list. 🤝 Read below how Carabiner Group increased pipeline by 30% through participation in Pavilion and how involvement opened doors for their CRO, Cliff Simon, and his organization ⤵

Classical source of the motto#Annuitcœptis (meaning "He favours our undertakings") and the other motto on the reverse of the Great Seal, #Novusordoseclorum (meaning "new order of the ages"), can both be traced to lines by the Roman poet Virgil. Out of many, one #EPluribusUnum. Educational Notes. “Out of many, one.” This is the literal translation for the motto of the #UnitedStatesofAmerica. It was a motto suggested by a committee on July 4, 1776. American Three Latin phrases, namely annuit cœptis “[He] has approved our undertakings,” novus ordo seclorum “a new order of the ages,” and e pluribus unum “out of many, one,” appear on the Great Seal of the United States While its status as national motto was for many years unofficial, E pluribus unum was still considered the de facto motto of the United States from its early history. Eventually, the U.S. Congress passed an act in 1956 (H. J. Resolution 396), adopting "In God We Trust" as the official motto. #InGODweTrust #wethepeople #onenationunderGOD #unitedwestand #GODBlessAmerica #AmericanMade #Americans #Family #NationsUnited #humanity #love #Creators #Watchers #influencers #tobravelygowherenomanhasgonebefore #asabovesobelow #community #Freedom #Speech #religion #MomLife #DadLife

🌟 Megan Rapinoe's insights in this feature by RealLeaders magazine are both powerful and inspiring. From her heartfelt reflection on her soccer journey to her passionate commitment to pay equity, diversity, and inclusion, Rapinoe continues to use her platform for impactful change. Her emphasis on creating safe and inclusive spaces, the urgency for companies to adopt tools like Trusaic's PayParity technology, and the broader call for systemic transformation resonates deeply. It's a powerful reminder for us all - whether in the corporate world or not - that every step toward equality, no matter how small, is a leap forward. Let's commit ourselves to be the change-makers and barrier-breakers our society needs. #PayEquity #DiversityAndInclusion #RealLeaders #MeganRapinoe

well worth a read - https://lnkd.in/eyAYdpS4

The Gracie Family - Circa 1996 From right to left: Rishna Gracie (CEO of Gracie Executive Protection), Ryron Gracie, Royce Gracie, Rilion Gracie, Rorion Gracie, Relson Gracie, Carlson Gracie, Helio Gracie HONOR, INTEGRITY, COMMITMENT, and LEGACY. These are but a few words that describe our families principles, and what you'll receive with the services we provide.

We see you #Dallas!! Check out this list of upcoming events and mark your calendars for some new experiences in the heart of Texas! 🌟 Comment which ones you'll be attending down below.

CYTOMOS' TRANSFORMATIVE CELL ANALYSIS TECHNOLOGY Dr Lindsay Fraser - Cytomos' Chief Scientific Officer - delivered a great presentation on Cytomos' groundbreaking AuraCyt™️ cell analysis technology at the BIA’s 2023 BioProcessUK Dragon’s Den session held on 30 November.   AuraCyt™️ is securing leading industry recognition as a technological innovation that provides information on cell properties that no other process analytical technology (PAT) can. The capability to collect a multitude of data that measures the intrinsic properties of individual cells in real-time, and to obtain a unique profile for subsequent downstream analysis and characterisation, is set to radically change the way that processes are monitored, whilst transforming velocity in biopharmaceutical R&D and fundamentally changing bioprocess PAT adaptation.   The fast and scalable AuraCyt™️ platform closely monitors a broad range of individual cell features simultaneously, to provide label-free, unbiased, consistent, accurate and reliable predictive analytics for biomanufacturing and other applications. AuraCyt™️ can save and optimise batches, addressing pressing industry needs for smarter, less labour-intensive, and more automated processes capable of driving down biomanufacturing costs and realising scale-out in the manufacture of personalised, regenerative medicines.   The AuraCyt™️ platform improves the pace and accuracy of single cell analysis. The ground-breaking technology harnesses the power of dielectric spectroscopy and Cytomos’ proprietary silicon chip sensors to enable researchers and scientists across the life science industry to generate unique fingerprints to characterise cells without the requirement for labels. The technology has the potential to be incorporated in-line, allowing real-time monitoring of cell manufacturing events and predicting manufacturing success. AuraCyt™️ is a compatible asset that is usable both alongside flow cytometry technologies or on its own.